/+/ Références
Mair J, Hammerer-Lercher A, Puschendorf B, et al. (2001). The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39(7): 571–88
Ray P, Birolleau S, Lefort Y, et al. (2006). Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis. Crit Care 10(3): R82
Maisel A, Krishnaswamy P, Nowak R, et al. (2002). Rapid measurement of B-type natriuetic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161–7
Ray P, Arthaud M, Lefort Y, et al;EPIDASA Study Group (2004). Usefulness of B-type natriuetic peptide in elderly patients with acute dyspnea. Intensive Care Med 30 (12): 2230–6
Berdague P, Caffin PY, Barazer I, et al. (2006). Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J 151(3): 690–8
Kazanegra R, Cheng V, Garcia A, et al (2001). A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7(1): 21–9
Logeart D, Thabut G, Jourdain P, et al. (2004). Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 43(4): 635–41
St Peter JV, Hartley GG, Murakami MM, et al. (2006). B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery. Clin Chem 52(4): 680–5
Das SR, Drazner MH, Dries DL, et al. (2005). Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112(14): 2163–8
Kraser DG, Lloyd-Jones DM, Chae CU, et al. (2005). Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149(4): 744–50
Daniels LB, Clopton P, Bhalla V, et al. (2006). How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J 151(5): 999–1005
Horwich TB, Hamilton MA, Fonarow GC (2006). B-type natriruetic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47(1):85–90
Kroll MH, Srisawasdi P (2007). The clearance of BNP modeled using the NT-proBNP-BNP relationship. Biosystems 88(1–2): 147–55
Luchner A, Hengstenberg C, Lowel H, et al. (2005). Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46(1): 118–23
McCullough PA, Duc P, Omland T, et al.;Breathing Not Properly Multinational Study Investigators (2003). B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41(3): 571–9
Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. (2006). Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47(1): 91–7
Mallamaci F, Zoccali C, Tripepi G, et al.;CREED Investigstors (2001). The Cardiovascular Risk Extended Evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59(4): 1559–66
Mark PB, Stewart GA, Gansevoort RT, et al. (2006). Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 21(2): 402–10
Safley DM, Awad A, Sullivan RA, et al. (2005). Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis 12: 117–24.
Goto T, Takase H, Toriyama T, et al. (2002). Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92(3): 610–5
Naganuma T, Sugimura K, Wada S, et al. (2002). The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22(5–6): 437–44
Ishii J, Nomura M, Okuma T, et al. (2001). Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta 312(1–2): 69–79
Mallamaci F, Tripepi G, Cutrupi S, et al. (2005). Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67(6): 2330–7
Pereira M, Azevedo A, Severo M, et al. (2007). Long-term stability of endogenous B-type natriuretic peptide during storage at −20 degrees C for later measurement with Biosite Triage assay. Clin Biochem 40: 1104–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cristol, JP., Sabatier, R., Belin, A. et al. Table ronde BNP: Discussions entre cliniciens et biologistes sur le peptide natriurétique de type B. Bio trib. mag. 23, 9–18 (2007). https://doi.org/10.1007/s11834-007-0009-2
Issue Date:
DOI: https://doi.org/10.1007/s11834-007-0009-2